Navigation Links
U.S. Patent Office to Issue 11 Patents for Nyxoah's Sleep Apnea Innovative Implant Technology
Date:11/6/2013

BRUSSELS and TEL AVIV, Israel, November 6, 2013 /PRNewswire/ --

Nyxoah, a Belgian-Israeli start-up company that develops a tiny implant for treating sleep apnea and snoring, announced today that the U.S. Patent and Trademark Office (USPTO) is issuing 11 patents for Nyxoah's obstructive sleep apnea technology. The first eight granted patents were published today on the USPTO website. Three more granted patents will be published in the coming weeks.  

     (Photo: http://photos.prnewswire.com/prnh/20131106/649781 )

One out of every five adults over the age of 40 suffers from some degree of obstructive sleep apnea (OSA), which can lead to hypertension, obesity, heart disease and stroke. OSA occurs when the tongue muscle relaxes during sleep, causing the tongue to fall back into the throat, blocking airflow. Nyxoah developed an innovative ultra-small implant that stimulates the tongue muscle to prevent airway blockage. In a short outpatient procedure, a flexible implant the size of a coin and thinner than a few sheets of paper is inserted under a patient's chin with a minimally invasive small incision. Then, before bed each night, the patient places a disposable adhesive battery patch on the underside of the chin, to wirelessly deliver energy to the nerves around the tongue throughout the night, completely preventing airway blockage during the night's sleep.

"The company initiated first-in-man studies, and the fact that we were able to so quickly protect the technology with a portfolio of patents adds significantly to the promise of this company," said Robert Taub, one of Nyxoah's co-founders.  

Dr. Adi Mashiach, Nyxoah's other co-founder, CEO, and inventor elaborated, "There are many groundbreaking aspects to our solution. Being able to stimulate the tongue muscle all night using a small disposable battery patch is a major innovation. And our ability to enable minimally invasive implantation in a quick outpatient setting should open the procedure to a significant percentage of the affected population. The fact that 11 patents were allowed less than a year from the date we filed them, is a testament to the uniqueness of our solution."  

Gerson Panitch, the patent lawyer at Finnegan who developed Nyxoah's IP strategy agrees. "Through careful strategic patent planning, we isolated dozens of critical features, and then pursued those strategies most likely to protect the company's value," Panitch explained. "The patents are designed to work together, providing a web of protection for Nyxoah. Eleven U.S. patents may seem like a lot to receive all at once, but there are many more in the pipeline," Panitch added.

About Nyxoah:

Nyxoah is a clinical-stage medical device start-up company focusing on neuromuscular electrical stimulation treatment of OSA. Nyxoah is headquartered in Brussels, Belgium, with R&D facilities there and in Tel Aviv, Israel. It was founded by Mr. Robert Taub and Dr. Adi Mashiach in 2009.

Media Contact:
Edan Ring
Unik Public Image for Nyxoah
+972-54-6680085
edan@unik.co.il


'/>"/>
SOURCE Nyxoah
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Spherix Announces Private Placement as the Company Continues to Execute its Patent Monetization Program - Spherix accepts $2.0 Million from Investors
2. General Patent Corporation Chairman and CEO Alexander Poltorak Joins Spherix Board Industry veteran and authority on patent law and valuation joins Spherix as director
3. Transposagen Issued Two Key U.S. Patents
4. US Patent Office Issues Patent for VG Life Sciences Peptide for HIV Treatment
5. ViaCyte Granted Over 20 Patents in 2013 Further Establishing the Company as a Leader in the Field of Regenerative Medicine
6. Consolidation, Patent Loses, Weak R&D Productivity Depress ITO Transactions in Life Sciences Segment: Everest Group Annual Report
7. Fingerprint Cards Purchases Key Wireless Patents
8. Convoy Therapeutics Granted Patent for Proprietary SPACE Technology
9. Histogen’s Composition for Hair Growth Receives US Patent
10. AppColl Introduces New Cloud-Based Patent Management Tool
11. Star Scientific Announces Patent Claims to Anatabine Citrate to be Granted by PTO
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Raleigh, NC (PRWEB) , ... June 24, 2016 , ... ... find the most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings ... here to read it now. , Diagnostic biomarkers are signposts in the blood, ...
(Date:6/23/2016)... /PRNewswire/ - FACIT has announced the creation of ... company, Propellon Therapeutics Inc. ("Propellon" or "the Company"), ... portfolio of first-in-class WDR5 inhibitors for the treatment ... represent an exciting class of therapies, possessing the ... cancer patients. Substantial advances have been achieved with ...
(Date:6/23/2016)...  The Prostate Cancer Foundation (PCF) is pleased to announce 24 ... for prostate cancer. Members of the Class of 2016 were selected from a ... Read More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... ... June 23, 2016 , ... STACS DNA Inc., the sample ... the Arkansas State Crime Laboratory, has joined STACS DNA as a Field Application Specialist. ... said Jocelyn Tremblay, President and COO of STACS DNA. “In further expanding our capacity ...
Breaking Biology Technology:
(Date:4/26/2016)... BANGALORE, India and LONDON ... Infosys Finacle, part of EdgeVerve Systems, a ... ), and Onegini today announced a partnership to ... banking solutions.      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ... banks to provide their customers enhanced security to ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
Breaking Biology News(10 mins):